ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alogliptin Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-1T8080
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Alogliptin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Alogliptin Market Research Report 2025

Code: QYRE-Auto-1T8080
Report
July 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Perrigo
Hikma Pharmaceuticals
Furiex Pharma
Allergan plc
Sanofi

Alogliptin Market

The global market for Alogliptin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Alogliptin is a selective, orally-bioavailable inhibitor of enzymatic activity of dipeptidyl peptidase-4 (DPP-4). Chemically, alogliptin is prepared as a benzoate salt and exists predominantly as the R-enantiomer (>99%). 
North American market for Alogliptin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Alogliptin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Alogliptin include Takeda, Perrigo, Hikma Pharmaceuticals, Furiex Pharma, Allergan, Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alogliptin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alogliptin.
The Alogliptin market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alogliptin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alogliptin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alogliptin Market Report

Report Metric Details
Report Name Alogliptin Market
Segment by Type
  • 6.25 Mg Tablet
  • 25 Mg Tablet
  • 12.5 Mg Tablet
  • 15 Mg Tablet
  • Other
Segment by Application
  • Diabetes
  • Hypercholesterolemia
  • Obesity
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, Perrigo, Hikma Pharmaceuticals, Furiex Pharma, Allergan, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alogliptin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alogliptin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Alogliptin Market report?

Ans: The main players in the Alogliptin Market are Takeda, Perrigo, Hikma Pharmaceuticals, Furiex Pharma, Allergan, Sanofi

What are the Application segmentation covered in the Alogliptin Market report?

Ans: The Applications covered in the Alogliptin Market report are Diabetes, Hypercholesterolemia, Obesity, Other

What are the Type segmentation covered in the Alogliptin Market report?

Ans: The Types covered in the Alogliptin Market report are 6.25 Mg Tablet, 25 Mg Tablet, 12.5 Mg Tablet, 15 Mg Tablet, Other

1 Alogliptin Market Overview
1.1 Product Definition
1.2 Alogliptin by Type
1.2.1 Global Alogliptin Market Value Comparison by Type (2024 VS 2031)
1.2.2 6.25 Mg Tablet
1.2.3 25 Mg Tablet
1.2.4 12.5 Mg Tablet
1.2.5 15 Mg Tablet
1.2.6 Other
1.3 Alogliptin by Application
1.3.1 Global Alogliptin Market Value by Application (2024 VS 2031)
1.3.2 Diabetes
1.3.3 Hypercholesterolemia
1.3.4 Obesity
1.3.5 Other
1.4 Global Alogliptin Market Size Estimates and Forecasts
1.4.1 Global Alogliptin Revenue 2020-2031
1.4.2 Global Alogliptin Sales 2020-2031
1.4.3 Global Alogliptin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Alogliptin Market Competition by Manufacturers
2.1 Global Alogliptin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Alogliptin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Alogliptin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Alogliptin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alogliptin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alogliptin, Product Type & Application
2.7 Global Key Manufacturers of Alogliptin, Date of Enter into This Industry
2.8 Global Alogliptin Market Competitive Situation and Trends
2.8.1 Global Alogliptin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Alogliptin Players Market Share by Revenue
2.8.3 Global Alogliptin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alogliptin Market Scenario by Region
3.1 Global Alogliptin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Alogliptin Sales by Region: 2020-2031
3.2.1 Global Alogliptin Sales by Region: 2020-2025
3.2.2 Global Alogliptin Sales by Region: 2026-2031
3.3 Global Alogliptin Revenue by Region: 2020-2031
3.3.1 Global Alogliptin Revenue by Region: 2020-2025
3.3.2 Global Alogliptin Revenue by Region: 2026-2031
3.4 North America Alogliptin Market Facts & Figures by Country
3.4.1 North America Alogliptin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Alogliptin Sales by Country (2020-2031)
3.4.3 North America Alogliptin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alogliptin Market Facts & Figures by Country
3.5.1 Europe Alogliptin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Alogliptin Sales by Country (2020-2031)
3.5.3 Europe Alogliptin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alogliptin Market Facts & Figures by Region
3.6.1 Asia Pacific Alogliptin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Alogliptin Sales by Region (2020-2031)
3.6.3 Asia Pacific Alogliptin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alogliptin Market Facts & Figures by Country
3.7.1 Latin America Alogliptin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Alogliptin Sales by Country (2020-2031)
3.7.3 Latin America Alogliptin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alogliptin Market Facts & Figures by Country
3.8.1 Middle East and Africa Alogliptin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Alogliptin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Alogliptin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alogliptin Sales by Type (2020-2031)
4.1.1 Global Alogliptin Sales by Type (2020-2025)
4.1.2 Global Alogliptin Sales by Type (2026-2031)
4.1.3 Global Alogliptin Sales Market Share by Type (2020-2031)
4.2 Global Alogliptin Revenue by Type (2020-2031)
4.2.1 Global Alogliptin Revenue by Type (2020-2025)
4.2.2 Global Alogliptin Revenue by Type (2026-2031)
4.2.3 Global Alogliptin Revenue Market Share by Type (2020-2031)
4.3 Global Alogliptin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Alogliptin Sales by Application (2020-2031)
5.1.1 Global Alogliptin Sales by Application (2020-2025)
5.1.2 Global Alogliptin Sales by Application (2026-2031)
5.1.3 Global Alogliptin Sales Market Share by Application (2020-2031)
5.2 Global Alogliptin Revenue by Application (2020-2031)
5.2.1 Global Alogliptin Revenue by Application (2020-2025)
5.2.2 Global Alogliptin Revenue by Application (2026-2031)
5.2.3 Global Alogliptin Revenue Market Share by Application (2020-2031)
5.3 Global Alogliptin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Alogliptin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Alogliptin Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Perrigo
6.2.1 Perrigo Company Information
6.2.2 Perrigo Description and Business Overview
6.2.3 Perrigo Alogliptin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Perrigo Alogliptin Product Portfolio
6.2.5 Perrigo Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Company Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Alogliptin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hikma Pharmaceuticals Alogliptin Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Furiex Pharma
6.4.1 Furiex Pharma Company Information
6.4.2 Furiex Pharma Description and Business Overview
6.4.3 Furiex Pharma Alogliptin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Furiex Pharma Alogliptin Product Portfolio
6.4.5 Furiex Pharma Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Company Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Alogliptin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Allergan Alogliptin Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Company Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Alogliptin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi Alogliptin Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alogliptin Industry Chain Analysis
7.2 Alogliptin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alogliptin Production Mode & Process Analysis
7.4 Alogliptin Sales and Marketing
7.4.1 Alogliptin Sales Channels
7.4.2 Alogliptin Distributors
7.5 Alogliptin Customer Analysis
8 Alogliptin Market Dynamics
8.1 Alogliptin Industry Trends
8.2 Alogliptin Market Drivers
8.3 Alogliptin Market Challenges
8.4 Alogliptin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Takeda
Perrigo
Hikma Pharmaceuticals
Furiex Pharma
Allergan plc
Sanofi
List of Tables
 Table 1. Global Alogliptin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Alogliptin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Alogliptin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Alogliptin Sales (M Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Alogliptin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Alogliptin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Alogliptin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Alogliptin Average Price (US$/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Alogliptin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Alogliptin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Alogliptin, Product Type & Application
 Table 12. Global Key Manufacturers of Alogliptin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alogliptin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alogliptin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alogliptin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Alogliptin Sales by Region (2020-2025) & (M Pcs)
 Table 18. Global Alogliptin Sales Market Share by Region (2020-2025)
 Table 19. Global Alogliptin Sales by Region (2026-2031) & (M Pcs)
 Table 20. Global Alogliptin Sales Market Share by Region (2026-2031)
 Table 21. Global Alogliptin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Alogliptin Revenue Market Share by Region (2020-2025)
 Table 23. Global Alogliptin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Alogliptin Revenue Market Share by Region (2026-2031)
 Table 25. North America Alogliptin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Alogliptin Sales by Country (2020-2025) & (M Pcs)
 Table 27. North America Alogliptin Sales by Country (2026-2031) & (M Pcs)
 Table 28. North America Alogliptin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Alogliptin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Alogliptin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Alogliptin Sales by Country (2020-2025) & (M Pcs)
 Table 32. Europe Alogliptin Sales by Country (2026-2031) & (M Pcs)
 Table 33. Europe Alogliptin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Alogliptin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Alogliptin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Alogliptin Sales by Region (2020-2025) & (M Pcs)
 Table 37. Asia Pacific Alogliptin Sales by Region (2026-2031) & (M Pcs)
 Table 38. Asia Pacific Alogliptin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Alogliptin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Alogliptin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Alogliptin Sales by Country (2020-2025) & (M Pcs)
 Table 42. Latin America Alogliptin Sales by Country (2026-2031) & (M Pcs)
 Table 43. Latin America Alogliptin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alogliptin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Alogliptin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Alogliptin Sales by Country (2020-2025) & (M Pcs)
 Table 47. Middle East and Africa Alogliptin Sales by Country (2026-2031) & (M Pcs)
 Table 48. Middle East and Africa Alogliptin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Alogliptin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Alogliptin Sales (M Pcs) by Type (2020-2025)
 Table 51. Global Alogliptin Sales (M Pcs) by Type (2026-2031)
 Table 52. Global Alogliptin Sales Market Share by Type (2020-2025)
 Table 53. Global Alogliptin Sales Market Share by Type (2026-2031)
 Table 54. Global Alogliptin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Alogliptin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Alogliptin Revenue Market Share by Type (2020-2025)
 Table 57. Global Alogliptin Revenue Market Share by Type (2026-2031)
 Table 58. Global Alogliptin Price (US$/Pcs) by Type (2020-2025)
 Table 59. Global Alogliptin Price (US$/Pcs) by Type (2026-2031)
 Table 60. Global Alogliptin Sales (M Pcs) by Application (2020-2025)
 Table 61. Global Alogliptin Sales (M Pcs) by Application (2026-2031)
 Table 62. Global Alogliptin Sales Market Share by Application (2020-2025)
 Table 63. Global Alogliptin Sales Market Share by Application (2026-2031)
 Table 64. Global Alogliptin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Alogliptin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Alogliptin Revenue Market Share by Application (2020-2025)
 Table 67. Global Alogliptin Revenue Market Share by Application (2026-2031)
 Table 68. Global Alogliptin Price (US$/Pcs) by Application (2020-2025)
 Table 69. Global Alogliptin Price (US$/Pcs) by Application (2026-2031)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 73. Takeda Alogliptin Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. Perrigo Company Information
 Table 76. Perrigo Description and Business Overview
 Table 77. Perrigo Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 78. Perrigo Alogliptin Product
 Table 79. Perrigo Recent Developments/Updates
 Table 80. Hikma Pharmaceuticals Company Information
 Table 81. Hikma Pharmaceuticals Description and Business Overview
 Table 82. Hikma Pharmaceuticals Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 83. Hikma Pharmaceuticals Alogliptin Product
 Table 84. Hikma Pharmaceuticals Recent Developments/Updates
 Table 85. Furiex Pharma Company Information
 Table 86. Furiex Pharma Description and Business Overview
 Table 87. Furiex Pharma Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 88. Furiex Pharma Alogliptin Product
 Table 89. Furiex Pharma Recent Developments/Updates
 Table 90. Allergan Company Information
 Table 91. Allergan Description and Business Overview
 Table 92. Allergan Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 93. Allergan Alogliptin Product
 Table 94. Allergan Recent Developments/Updates
 Table 95. Sanofi Company Information
 Table 96. Sanofi Description and Business Overview
 Table 97. Sanofi Alogliptin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 98. Sanofi Alogliptin Product
 Table 99. Sanofi Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Alogliptin Distributors List
 Table 103. Alogliptin Customers List
 Table 104. Alogliptin Market Trends
 Table 105. Alogliptin Market Drivers
 Table 106. Alogliptin Market Challenges
 Table 107. Alogliptin Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alogliptin
 Figure 2. Global Alogliptin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alogliptin Market Share by Type: 2024 & 2031
 Figure 4. 6.25 Mg Tablet Product Picture
 Figure 5. 25 Mg Tablet Product Picture
 Figure 6. 12.5 Mg Tablet Product Picture
 Figure 7. 15 Mg Tablet Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Alogliptin Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Alogliptin Market Share by Application: 2024 & 2031
 Figure 11. Diabetes
 Figure 12. Hypercholesterolemia
 Figure 13. Obesity
 Figure 14. Other
 Figure 15. Global Alogliptin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Alogliptin Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Alogliptin Sales (2020-2031) & (M Pcs)
 Figure 18. Global Alogliptin Average Price (US$/Pcs) & (2020-2031)
 Figure 19. Alogliptin Report Years Considered
 Figure 20. Alogliptin Sales Share by Manufacturers in 2024
 Figure 21. Global Alogliptin Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Alogliptin Players: Market Share by Revenue in Alogliptin in 2024
 Figure 23. Alogliptin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Alogliptin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Alogliptin Sales Market Share by Country (2020-2031)
 Figure 26. North America Alogliptin Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Alogliptin Sales Market Share by Country (2020-2031)
 Figure 30. Europe Alogliptin Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Alogliptin Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Alogliptin Revenue Market Share by Region (2020-2031)
 Figure 38. China Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Alogliptin Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Alogliptin Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Alogliptin Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Alogliptin Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Alogliptin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Alogliptin by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Alogliptin by Type (2020-2031)
 Figure 60. Global Alogliptin Price (US$/Pcs) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Alogliptin by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Alogliptin by Application (2020-2031)
 Figure 63. Global Alogliptin Price (US$/Pcs) by Application (2020-2031)
 Figure 64. Alogliptin Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Alogliptin Benzoate Reagent Market Research Report 2024
Global Sitagliptin Intermediates Market Research Report 2024
Global Alogliptin Benzoate Tablet Market Research Report 2024
Dipeptidyl Peptidase 4 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tagliptin Market Research Report 2024
Dipeptidyl Peptidase IV DPP IV Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Linagliptin Market Research Report 2024
Global Sitagliptin API Market Research Report 2025
Global Sitagliptin Phosphate API Market Research Report 2025
Global Saxagliptin API Market Research Report 2024
DPP 4 Inhibitor Hypoglycemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antidiabetic Drugs Market Insights Forecast to 2030
Global DPP 4 Inhibitors for Type 2 Diabetes Treatment Market Research Report 2025
Global Vildagliptin Market Research Report 2024
Global Oral Anti Diabetic Drug Market Insights Forecast to 2030
Sitagliptin Phosphate Market
Global Oral Antidiabetic Agents Market Insights Forecast to 2030
Global GLP 1 Drug Peptide API Market Research Report 2024
Global Leupeptin Market Research Report 2024
Global Sitagliptin Tablet Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions